In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione.
Hexokinase (E.C. 2.7.1.1), the enzyme responsible for glucose phosphorylation to G-6P, is inactivated by SH reagents and oxyradicals, and its inhibition has been involved in heavy metal toxicity in mammalian systems. In this work, the possibility that hexokinase activity could be affected by both heavy metal binding and oxidative stress conditions also in mussel tissues (Mytilus galloprovincialis Lam.) was investigated. The results obtained in vitro demonstrate that heavy metals inhibited digestive gland hexokinase (with Cd2+ > Cu2+ > Hg2+ > Zn2+ > Pb2+) and suggest a role for GSH in the protection against the heavy metal effects. Hexokinase activity was also reduced by addition of iron/ascorbate, indicating a susceptibility of the enzyme to metal-mediated oxyradical production. The effects of Cu2+ treatment (3 days, 40 micrograms l-1 per animal) on hexokinase activity and on the GSH/GSSG status were then evaluated in mussels exposed to a cycle of air exposure/reimmersion. In Cu-exposed mussels, a significant decrease in hexokinase activity and a parallel reduction in tissue GSH levels were observed, suggesting that the two effects of metal treatment could be related; however, hexokinase activity progressively recovered during air exposure and reimmersion, whereas the level of GSH showed a further decrease during air exposure followed by recovery after reimmersion. The in vitro results therefore indicate that mussel digestive gland hexokinase is susceptible to inactivation by heavy metal binding and suggest a role for GSH in the protection against the effects of heavy metals. The effects of copper were confirmed by the results obtained in vivo. The possible relationship between hexokinase activity and the level of GSH in the digestive gland of control and Cu-exposed mussels during air exposure and reimmersion are discussed, taking into account the balance between pro-oxidant and antioxidant processes at different stages of exposure.
Canesi
L
L
Istituto di Anatomia e Fisiologia, Crocicchia, Urbino, Italy.
Ciacci
C
C
Piccoli
G
G
Stocchi
V
V
Viarengo
A
A
Gallo
G
G
D000818:Animals; D049872:Bivalvia / Q000187:drug effects* / Q000502:physiology; D002104:Cadmium / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism*; D019803:Glutathione Disulfide / Q000378:metabolism; D006593:Hexokinase / Q000037:antagonists & inhibitors*; D066298:In Vitro Techniques; D007854:Lead / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D019216:Metals, Heavy / Q000494:pharmacology*; D018384:Oxidative Stress; D010766:Phosphorylation; D015032:Zinc / Q000494:pharmacology
D019216:Metals, Heavy; D002104:Cadmium; D007854:Lead; D003300:Copper; D006593:Hexokinase; D005952:Glucose-6-Phosphatase; D008628:Mercury; D005978:Glutathione; D005947:Glucose; D015032:Zinc; D019803:Glutathione Disulfide